CRNX - Crinetics Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

CRNX is currently covered by 9 analysts with an average price target of $60.58. This is a potential upside of $17.26 (39.84%) from yesterday's end of day stock price of $43.32.

Crinetics Pharmaceuticals's activity chart (see below) currently has 21 price targets and 48 ratings on display. The stock rating distribution of CRNX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.22% with an average time for these price targets to be met of 399.5 days.

Highest price target for CRNX is $80, Lowest price target is $35, average price target is $60.58.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 28-Mar-2024. First documented stock forecast 13-Aug-2018.

Currently out of the existing stock ratings of CRNX, 34 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

80

$36.68 (84.67%)

60

28 days ago

6/10 (60%)

$33.19 (70.90%)

442

Buy

50

$6.68 (15.42%)

42

1 months 12 days ago

8/9 (88.89%)

$9.5 (23.46%)

435

Buy

54

$10.68 (24.65%)

48

1 months 12 days ago

3/4 (75%)

$13.5 (33.33%)

132

Buy

65

$21.68 (50.05%)

50

1 months 21 days ago

0/4 (0%)

$21.49 (49.39%)

Buy

52

$8.68 (20.04%)

45

1 months 27 days ago

3/4 (75%)

$11.06 (27.02%)

252

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRNX (Crinetics Pharmaceuticals) average time for price targets to be met?

On average it took 399.5 days on average for the stock forecasts to be realized with a an average price target met ratio 63.22

Which analyst has the current highest performing score on CRNX (Crinetics Pharmaceuticals) with a proven track record?

BRIAN SKORNEY

Which analyst has the most public recommendations on CRNX (Crinetics Pharmaceuticals)?

Brian Skorney works at BAIRD and has 0 price targets and 2 ratings on CRNX

Which analyst is the currently most bullish on CRNX (Crinetics Pharmaceuticals)?

Jonathan Wolleben with highest potential upside - $36.68

Which analyst is the currently most reserved on CRNX (Crinetics Pharmaceuticals)?

Jessica Fye with lowest potential downside - -$8.32

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?